VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 50 filers reported holding VOR BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,638,866 | -31.2% | 1,716,446 | +0.2% | 0.00% | – |
Q2 2023 | $5,291,567 | -37.7% | 1,712,481 | +8.4% | 0.00% | – |
Q1 2023 | $8,496,623 | +7.2% | 1,579,298 | +32.6% | 0.00% | – |
Q4 2022 | $7,922,344 | +202.8% | 1,191,330 | +81.3% | 0.00% | – |
Q3 2022 | $2,616,000 | -19.9% | 657,142 | 0.0% | 0.00% | – |
Q2 2022 | $3,266,000 | -18.1% | 657,142 | -0.5% | 0.00% | – |
Q1 2022 | $3,989,000 | -63.9% | 660,447 | -30.6% | 0.00% | – |
Q4 2021 | $11,064,000 | -45.8% | 952,126 | -26.8% | 0.00% | -100.0% |
Q3 2021 | $20,400,000 | +29.7% | 1,301,056 | +54.3% | 0.00% | – |
Q2 2021 | $15,728,000 | -54.8% | 843,383 | +4.6% | 0.00% | -100.0% |
Q1 2021 | $34,763,000 | – | 806,562 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 6,361,723 | $73,923,000 | 13.88% |
RA Capital Management | 11,120,973 | $129,226,000 | 2.28% |
Paradigm Biocapital Advisors LP | 629,342 | $7,313,000 | 2.09% |
OUP Management Co., LLC | 374,714 | $4,354,000 | 1.96% |
JOHNSON & JOHNSON | 1,074,658 | $12,488,000 | 1.42% |
Sarissa Capital Management LP | 707,010 | $8,215,000 | 0.71% |
Woodline Partners LP | 1,111,123 | $12,911,000 | 0.18% |
Artal Group S.A. | 550,000 | $6,391,000 | 0.17% |
Orbimed Advisors | 833,333 | $9,683,000 | 0.12% |
Laurion Capital Management LP | 857,308 | $9,962,000 | 0.10% |